Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415
Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Neuro-Oncology
|
June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539
C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial
Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2021
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126
William A Hall, Snehal Deshmukh, Deborah W Bruner, et al.
Neuro-Oncology
|
November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825
Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.
JAMA Oncology
|
April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial
Samuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
Cancer
|
December 29, 2022
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126
Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415
Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203
Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Neuro-Oncology
|
June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539
C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial
Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2021
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126
William A Hall, Snehal Deshmukh, Deborah W Bruner, et al.
Neuro-Oncology
|
November 16, 2024
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825
Joshua D Strauss, Mark R Gilbert, Minesh Mehta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
Christopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.
JAMA Oncology
|
April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial
Samuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
Cancer
|
December 29, 2022
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126
Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, et al.
Page
of 23